4.4 Article

New 1,2,4-Triazole Scaffolds as Anticancer Agents: Synthesis, Biological Evaluation and Docking Studies

Related references

Note: Only part of the references are listed.
Article Chemistry, Multidisciplinary

Design, Synthesis, Molecular Modeling, Anticancer Studies, and Density Functional Theory Calculations of 4-(1,2,4-Triazol-3-ylsulfanylmethyl)-1,2,3-triazole Derivatives

Adeeb Al Sheikh Ali et al.

Summary: New conjugates of 1,2,3-triazoles linked to 1,2,4-triazoles were synthesized and screened for anticancer activity against various cancer cell lines, showing promising results. The compounds with the highest potency demonstrated superior interactions with the target protein and exhibited significant anticancer activity. DFT calculations were performed to confirm the results of molecular docking and experimental findings.

ACS OMEGA (2021)

Article Chemistry, Physical

Synthesis, Characterization, and Antioxidant and Anticancer Activity of 1,4-Disubstituted 1,2,3-triazoles

Irfan Sahin et al.

Summary: This study synthesized six 1,2,3-triazole derivatives and investigated their antioxidant and anticancer activities. The results showed that some of the compounds exhibited significant anticancer activity.

JOURNAL OF MOLECULAR STRUCTURE (2021)

Article Chemistry, Medicinal

2H-1,2,3-Triazole-chalcones as novel cytotoxic agents against prostate cancer

Sergio Pinheiro et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)

Review Urology & Nephrology

Systemic treatment for metastatic prostate cancer

Gwenaelle Gravis

ASIAN JOURNAL OF UROLOGY (2019)

Article Biochemistry & Molecular Biology

A novel FGFR1-binding peptide exhibits anti-tumor effect on lung cancer by inhibiting proliferation and angiogenesis

Qiaoyan Tan et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)

Review Pharmacology & Pharmacy

AKT in cancer: new molecular insights and advances in drug development

Prabhjot S. Mundi et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)

Review Oncology

FGFR Signaling as a Target for Lung Cancer Therapy

Arpita Desai et al.

JOURNAL OF THORACIC ONCOLOGY (2016)

Review Cell Biology

FGFR1 inhibition in lung squamous cell carcinoma: questions and controversies

C. E. Weeden et al.

CELL DEATH DISCOVERY (2015)

Article Pharmacology & Pharmacy

Synthesis, antifungal and antibacterial activity of novel 1,2,4-triazole derivatives

Deepa Gupta et al.

JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH (2015)

Review Chemistry, Organic

1,2,4-Triazoles: A Review of Synthetic Approaches and the Biological Activity

Suresh Maddila et al.

LETTERS IN ORGANIC CHEMISTRY (2013)

Article Oncology

FGFR1 Amplification in Squamous Cell Carcinoma of The Lung

Rebecca S. Heist et al.

JOURNAL OF THORACIC ONCOLOGY (2012)

Review Chemistry, Multidisciplinary

Synthesis of 3,4,5-Trisubstituted-1,2,4-triazoles

Aline Moulin et al.

CHEMICAL REVIEWS (2010)

Article Chemistry, Medicinal

Molecular properties prediction, synthesis and antimicrobial activity of some newer oxadiazole derivatives

Mohammed Afroz Bakht et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)

Review Pathology

PTEN and the PI3-Kinase Pathway in Cancer

Nader Chalhoub et al.

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)

Review Biochemistry & Molecular Biology

AKT/PKB signaling: Navigating downstream

Brendan D. Manning et al.

Article Chemistry, Multidisciplinary

The E factor: fifteen years on

Roger A. Sheldon

GREEN CHEMISTRY (2007)

Article Biotechnology & Applied Microbiology

The role of the medicinal chemist in drug discovery - Then and now

JG Lombardino et al.

NATURE REVIEWS DRUG DISCOVERY (2004)

Article Chemistry, Medicinal

Selection criteria for drug-like compounds

I Muegge

MEDICINAL RESEARCH REVIEWS (2003)

Article Biochemistry & Molecular Biology

Synthesis and in vitro leishmanicidal activity of some hydrazides and their analogues

KM Khan et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2003)

Article Chemistry, Medicinal

Molecular properties that influence the oral bioavailability of drug candidates

DF Veber et al.

JOURNAL OF MEDICINAL CHEMISTRY (2002)